DANBURY, Conn., July 17 /PRNewswire-FirstCall/ -- Penwest Pharmaceuticals Co. will conduct a conference call on Wednesday, July 26th at 11:00 a.m. ET to review its financial results for the second quarter of 2006, which will be released earlier that day. Operational developments and financial outlook will also be discussed on the call.
The conference call will include remarks by Jennifer Good, President and Chief Executive Officer, and Benjamin Palleiko, Senior Vice President, Corporate Development and Chief Financial Officer.
Domestic Telephone Number: 800-895-0231 International Telephone Number: 785-424-1054 The conference ID is “Penwest.”
Please dial in 10 minutes prior to the scheduled start time. The conference call will also be accessible live and as a replay on the Investor Relations section of the Penwest Web site at http://www.penwest.com.
If you have any questions, please contact Diane D’Alessandro of Penwest at 203-796-3700 or Caroline Gentile of Kekst and Company at 212-521-4800.
Penwest Pharmaceuticals Co.
CONTACT: Diane D’Alessandro of Penwest, +1-203-796-3700; or CarolineGentile of Kekst and Company, +1-212-521-4800
Web site: http://www.penwest.com/
